- Home
- EGY vs EBS Comparison
EGY vs EBS Comparison
Compare EGY & EBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EGY
- EBS
- Stock Information
- Founded
- EGY 1985
- EBS 1998
- Country
- EGY United States
- EBS United States
- Employees
- EGY N/A
- EBS N/A
- Industry
- EGY Oil & Gas Production
- EBS Biotechnology: Pharmaceutical Preparations
- Sector
- EGY Energy
- EBS Health Care
- Exchange
- EGY Nasdaq
- EBS Nasdaq
- Market Cap
- EGY 389.8M
- EBS 353.9M
- IPO Year
- EGY N/A
- EBS 2006
- Fundamental
- Price
- EGY $3.88
- EBS $6.99
- Analyst Decision
- EGY
- EBS Strong Buy
- Analyst Count
- EGY 0
- EBS 3
- Target Price
- EGY N/A
- EBS $14.33
- AVG Volume (30 Days)
- EGY 960.1K
- EBS 1.4M
- Earning Date
- EGY 08-05-2025
- EBS 08-05-2025
- Dividend Yield
- EGY 6.44%
- EBS N/A
- EPS Growth
- EGY N/A
- EBS N/A
- EPS
- EGY 0.56
- EBS N/A
- Revenue
- EGY $489,162,000.00
- EBS $965,400,000.00
- Revenue This Year
- EGY N/A
- EBS N/A
- Revenue Next Year
- EGY $24.62
- EBS $18.88
- P/E Ratio
- EGY $6.98
- EBS N/A
- Revenue Growth
- EGY 3.02
- EBS N/A
- 52 Week Low
- EGY $3.00
- EBS $4.02
- 52 Week High
- EGY $7.43
- EBS $15.10
- Technical
- Relative Strength Index (RSI)
- EGY 60.73
- EBS 59.80
- Support Level
- EGY $3.54
- EBS $6.21
- Resistance Level
- EGY $3.91
- EBS $6.95
- Average True Range (ATR)
- EGY 0.15
- EBS 0.39
- MACD
- EGY 0.00
- EBS 0.03
- Stochastic Oscillator
- EGY 68.69
- EBS 76.00
About EGY VAALCO Energy Inc.
VAALCO Energy Inc is an independent energy company operating in the United States. It is principally engaged in the acquisition, exploration, development, and production of crude oil and natural gas. The company operates through geographical segments namely Gabon, Egypt, Canada, Equatorial Guinea, and Cote d'Ivoire. The company generates maximum revenue from the Gabon segment.
About EBS Emergent Biosolutions Inc.
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.